1. Home
  2. PDX vs MRVI Comparison

PDX vs MRVI Comparison

Compare PDX & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PIMCO Dynamic Income Strategy Fund of Beneficial Interest

PDX

PIMCO Dynamic Income Strategy Fund of Beneficial Interest

HOLD

Current Price

$21.13

Market Cap

938.4M

Sector

Finance

ML Signal

HOLD

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$5.97

Market Cap

890.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDX
MRVI
Founded
2019
2014
Country
NY
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
938.4M
890.9M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
PDX
MRVI
Price
$21.13
$5.97
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$4.13
AVG Volume (30 Days)
78.9K
3.1M
Earning Date
01-01-0001
05-07-2026
Dividend Yield
4.95%
N/A
EPS Growth
N/A
14.29
EPS
N/A
N/A
Revenue
N/A
$185,743,000.00
Revenue This Year
N/A
$12.54
Revenue Next Year
N/A
$7.87
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.47
$1.99
52 Week High
$25.22
$6.55

Technical Indicators

Market Signals
Indicator
PDX
MRVI
Relative Strength Index (RSI) 54.33 66.68
Support Level $21.11 $3.27
Resistance Level $22.10 N/A
Average True Range (ATR) 0.28 0.31
MACD 0.03 0.02
Stochastic Oscillator 86.29 64.97

Price Performance

Historical Comparison
PDX
MRVI

About PDX PIMCO Dynamic Income Strategy Fund of Beneficial Interest

PIMCO Dynamic Income Strategy Fund is a non-diversified, limited-term, closed-end management investment company. It seeks current income as a primary objective and capital appreciation as a secondary objective. The fund makes investments using a dynamic asset allocation plan among multiple sectors in the public and private credit markets globally, including corporate debt, mortgage-related and other asset-backed instruments, government and sovereign debt, taxable municipal bonds, and other fixed, variable, and floating-rate income-producing securities of U.S. and foreign issuers, including emerging market issuers and real estate-related investments.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

Share on Social Networks: